Showing results (11-20 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|December 15, 2022
Expert consensus on indocyanine green fluorescence imaging for thoracoscopic lung resection (The Version 2022)Fei Cui, Jun Liu, Ming Du, et al.Translational Lung Cancer Research|December 15, 2022
Onco-biome in pharmacotherapy for lung cancer: a narrative reviewAkiko T Tateishi, Yusuke OkumaTranslational Lung Cancer Research|December 15, 2022
Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort studyKening Zhang, Chengzhi Zhou, Jiabo Gao, et al.Translational Lung Cancer Research|January 13, 2023
Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markersHongsheng Deng, Hengrui Liang, Jiawei Chen, et al.Translational Lung Cancer Research|January 13, 2023
Erratum to clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinomaTranslational Lung Cancer Research|June 13, 2022
Longitudinal prediction of lung nodule invasiveness by sequential modelling with common clinical computed tomography (CT) measurements: a prediction accuracy studyGuangyu Tao, Dejun Shi, Lingming Yu, et al.Translational Lung Cancer Research|June 13, 2022
Triptolide promotes degradation of the unfolded gain-of-function Tp53R175H/Y220C mutant protein by initiating heat shock protein 70 transcription in non-small cell lung cancerJie Zhou, Junwen Luo, Peiwei Li, et al.Translational Lung Cancer Research|June 13, 2022
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trialQuan Liu, Juan-Ying Xu, Ye-Hong Xu, et al.Translational Lung Cancer Research|July 14, 2022
Efficacy, prognosis and safety analysis of anti-PD-1/PD-L1 inhibitor rechallenge in advanced lung cancer patients: a cohort studyJin Yang, Ran Zeng, Jianping Zhou, et al.Translational Lung Cancer Research|July 14, 2022
Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathwayJiahan Cheng, Liang Xia, Xiaohu Hao, et al.Pageof 240